TX
Texas House Bill HB597

Texas 2015 - 84th Regular

Texas House Bill HB597 Compare Versions

OldNewDifferences
11 84R18895 JSC-D
22 By: Clardy, Price, Turner of Tarrant, H.B. No. 597
33 Harless, Villalba, et al.
44 Substitute the following for H.B. No. 597:
55 By: Herrero C.S.H.B. No. 597
66
77
88 A BILL TO BE ENTITLED
99 AN ACT
1010 relating to the designation for criminal prosecution and other
1111 purposes of certain chemicals commonly referred to as synthetic
1212 cannabinoids as controlled substances and controlled substance
1313 analogues under the Texas Controlled Substances Act; amending
1414 provisions subject to a criminal penalty.
1515 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
1616 SECTION 1. Sections 481.002(5) and (6), Health and Safety
1717 Code, are amended to read as follows:
1818 (5) "Controlled substance" means a substance,
1919 including a drug, an adulterant, and a dilutant, listed in
2020 Schedules I through V or Penalty Group [Groups] 1, 1-A, [or] 2, 2-A,
2121 3, or [through] 4. The term includes the aggregate weight of any
2222 mixture, solution, or other substance containing a controlled
2323 substance.
2424 (6) "Controlled substance analogue" means:
2525 (A) a substance with a chemical structure
2626 substantially similar to the chemical structure of a controlled
2727 substance in Schedule I or II or Penalty Group 1, 1-A, [or] 2, or
2828 2-A; or
2929 (B) a substance specifically designed to produce
3030 an effect substantially similar to, or greater than, the effect of a
3131 controlled substance in Schedule I or II or Penalty Group 1, 1-A,
3232 [or] 2, or 2-A.
3333 SECTION 2. Section 481.1031, Health and Safety Code, is
3434 amended to read as follows:
3535 Sec. 481.1031. PENALTY GROUP 2-A. (a) In this section:
3636 (1) "Core component" is one of the following:
3737 azaindole, benzimidazole, benzothiazole, carbazole, imidazole,
3838 indane, indazole, indene, indole, pyrazole, pyrazolopyridine,
3939 pyridine, or pyrrole.
4040 (2) "Group A component" is one of the following:
4141 adamantane, benzene, cycloalkylmethyl, isoquinoline,
4242 methylpiperazine, naphthalene, phenyl, quinoline,
4343 tetrahydronaphthalene, tetramethylcyclopropane, amino oxobutane,
4444 amino dimethyl oxobutane, amino phenyl oxopropane, methyl methoxy
4545 oxobutane, methoxy dimethyl oxobutane, methoxy phenyl oxopropane,
4646 or an amino acid.
4747 (3) "Link component" is one of the following
4848 functional groups: carboxamide, carboxylate, hydrazide, methanone
4949 (ketone), ethanone, methanediyl (methylene bridge), or methine.
5050 (b) Penalty Group 2-A consists of any material, compound,
5151 mixture, or preparation that contains any quantity of a natural or
5252 synthetic chemical substance, including its salts, isomers, and
5353 salts of isomers, listed by name in this subsection or contained
5454 within one of the structural classes defined in this subsection:
5555 (1) WIN-55,212-2;
5656 (2) Cyclohexylphenol: any compound [that is a
5757 cannabinoid receptor agonist and mimics the pharmacological effect
5858 of naturally occurring cannabinoids, including:
5959 [naphthoylindoles structurally derived from
6060 3-(1-naphthoyl)indole by substitution at the nitrogen atom of the
6161 indole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
6262 or 2-(4-morpholinyl)ethyl, whether or not further substituted in
6363 the indole ring to any extent, whether or not substituted in the
6464 napthyl ring to any extent, including:
6565 [AM-2201;
6666 [JWH-004;
6767 [JWH-007;
6868 [JWH-009;
6969 [JWH-015;
7070 [JWH-016;
7171 [JWH-018;
7272 [JWH-019;
7373 [JWH-020;
7474 [JWH-046;
7575 [JWH-047;
7676 [JWH-048;
7777 [JWH-049;
7878 [JWH-050;
7979 [JWH-073;
8080 [JWH-076;
8181 [JWH-079;
8282 [JWH-080;
8383 [JWH-081;
8484 [JWH-082;
8585 [JWH-083;
8686 [JWH-093;
8787 [JWH-094;
8888 [JWH-095;
8989 [JWH-096;
9090 [JWH-097;
9191 [JWH-098;
9292 [JWH-099;
9393 [JWH-100;
9494 [JWH-116;
9595 [JWH-122;
9696 [JWH-148;
9797 [JWH-149;
9898 [JWH-153;
9999 [JWH-159;
100100 [JWH-164;
101101 [JWH-165;
102102 [JWH-166;
103103 [JWH-180;
104104 [JWH-181;
105105 [JWH-182;
106106 [JWH-189;
107107 [JWH-193;
108108 [JWH-198;
109109 [JWH-200;
110110 [JWH-210;
111111 [JWH-211;
112112 [JWH-212;
113113 [JWH-213;
114114 [JWH-234;
115115 [JWH-235;
116116 [JWH-239;
117117 [JWH-240;
118118 [JWH-241;
119119 [JWH-242;
120120 [JWH-258;
121121 [JWH-259;
122122 [JWH-260;
123123 [JWH-262;
124124 [JWH-267;
125125 [JWH-386;
126126 [JWH-387;
127127 [JWH-394;
128128 [JWH-395;
129129 [JWH-397;
130130 [JWH-398;
131131 [JWH-399;
132132 [JWH-400;
133133 [JWH-412;
134134 [JWH-413; and
135135 [JWH-414;
136136 [naphthylmethylindones structurally derived from
137137 1H-indol-3-yl-(1-naphthyl)methane by substitution at the nitrogen
138138 atom of the indole ring by alkyl, alkenyl, cycloalkylmethyl,
139139 cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not further
140140 substituted in the indole ring to any extent, whether or not
141141 substituted in the naphthyl ring to any extent, including:
142142 [JWH-175;
143143 [JWH-184;
144144 [JWH-185;
145145 [JWH-192;
146146 [JWH-194;
147147 [JWH-195;
148148 [JWH-196;
149149 [JWH-197; and
150150 [JWH-199;
151151 [naphthoylpyrroles structurally derived from
152152 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the
153153 pyrrole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
154154 or 2-(4-morpholinyl)ethyl, whether or not further substituted in
155155 the pyrrole ring to any extent, whether or not substituted in the
156156 naphthyl ring to any extent, including:
157157 [JWH-030;
158158 [JWH-145;
159159 [JWH-146;
160160 [JWH-147;
161161 [JWH-150;
162162 [JWH-156;
163163 [JWH-243;
164164 [JWH-244;
165165 [JWH-245;
166166 [JWH-246;
167167 [JWH-292;
168168 [JWH-293;
169169 [JWH-307;
170170 [JWH-308;
171171 [JWH-309;
172172 [JWH-346;
173173 [JWH-347;
174174 [JWH-348;
175175 [JWH-363;
176176 [JWH-364;
177177 [JWH-365;
178178 [JWH-366;
179179 [JWH-367;
180180 [JWH-368;
181181 [JWH-369;
182182 [JWH-370;
183183 [JWH-371;
184184 [JWH-372;
185185 [JWH-373; and
186186 [JWH-392;
187187 [naphthylmethylindenes structurally derived from
188188 1-(1-naphthylmethyl)indene by substitution at the 3-position of
189189 the indene ring by alkyl, alkenyl, cycloalkylmethyl,
190190 cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not further
191191 substituted in the indene ring to any extent, whether or not
192192 substituted in the naphthyl ring to any extent, including:
193193 [JWH-171;
194194 [JWH-172;
195195 [JWH-173; and
196196 [JWH-176;
197197 [phenylacetylindoles structurally derived from
198198 3-phenylacetylindole by substitution at the nitrogen atom of the
199199 indole ring with alkyl, alkenyl, cycloalkylmethyl,
200200 cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not further
201201 substituted in the indole ring to any extent, whether or not
202202 substituted in the phenyl ring to any extent, including:
203203 [AM-694;
204204 [AM-1241;
205205 [JWH-167;
206206 [JWH-203;
207207 [JWH-204;
208208 [JWH-205;
209209 [JWH-206;
210210 [JWH-208;
211211 [JWH-237;
212212 [JWH-248;
213213 [JWH-249;
214214 [JWH-250;
215215 [JWH-251;
216216 [JWH-252;
217217 [JWH-253;
218218 [JWH-302;
219219 [JWH-303;
220220 [JWH-305;
221221 [JWH-306;
222222 [JWH-311;
223223 [JWH-312;
224224 [JWH-313;
225225 [JWH-314; and
226226 [JWH-315;
227227 [cyclohexylphenols] structurally derived from
228228 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of
229229 the phenolic ring [by alkyl], (N-methylpiperidin-2-yl)alkyl,
230230 (4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl [alkenyl,
231231 cycloalkylmethyl, cycloalkylethyl, or 2-(4-morpholinyl)ethyl],
232232 whether or not substituted in the cyclohexyl ring to any extent,
233233 including:
234234 JWH-337;
235235 JWH-344;
236236 CP-55,940;
237237 CP-47,497; and
238238 analogues of CP-47,497;
239239 (3) Cannabinol[, including VII, V, VIII, I, II, III,
240240 IV, IX, X, XI, XII, XIII, XV, and XVI;
241241 [JWH-337;
242242 [JWH-344;
243243 [JWH-345; and
244244 [JWH-405; and
245245 [cannabinol] derivatives, except where contained in
246246 marihuana, including tetrahydro derivatives of cannabinol and
247247 3-alkyl homologues of cannabinol or of its tetrahydro derivatives,
248248 such as:
249249 Nabilone;
250250 HU-210; and
251251 HU-211;
252252 (4) Tetramethylcyclopropyl thiazole: any compound
253253 structurally derived from 2,2,3,3-tetramethyl-N-(thiazol-
254254 2-ylidene)cyclopropanecarboxamide by substitution at the nitrogen
255255 atom of the thiazole ring, whether or not further substituted in the
256256 thiazole ring to any extent, whether or not substituted in the
257257 tetramethylcyclopropyl ring to any extent, including:
258258 A-836,339;
259259 (5) any compound containing a core component
260260 substituted at the 1-position to any extent, and substituted at the
261261 3-position with a link component attached to a group A component,
262262 whether or not the core component or group A component are further
263263 substituted to any extent, including:
264264 Naphthoylindane;
265265 Naphthoylindazole (THJ-018);
266266 Naphthyl methyl indene (JWH-171);
267267 Naphthoylindole (JWH-018);
268268 Quinolinoyl pyrazole carboxylate (Quinolinyl
269269 fluoropentyl fluorophenyl pyrazole carboxylate);
270270 Naphthoyl pyrazolopyridine; and
271271 Naphthoylpyrrole (JWH-030);
272272 (6) any compound containing a core component
273273 substituted at the 1-position to any extent, and substituted at the
274274 2-position with a link component attached to a group A component,
275275 whether or not the core component or group A component are further
276276 substituted to any extent, including:
277277 Naphthoylbenzimidazole (JWH-018 Benzimidazole);
278278 and
279279 Naphthoylimidazole;
280280 (7) any compound containing a core component
281281 substituted at the 3-position to any extent, and substituted at the
282282 2-position with a link component attached to a group A component,
283283 whether or not the core component or group A component are further
284284 substituted to any extent, including:
285285 Naphthoyl benzothiazole; and
286286 (8) any compound containing a core component
287287 substituted at the 9-position to any extent, and substituted at the
288288 3-position with a link component attached to a group A component,
289289 whether or not the core component or group A component are further
290290 substituted to any extent, including:
291291 Naphthoylcarbazole (EG-018) [and
292292 [WIN-55,212-2].
293293 SECTION 3. Section 481.106, Health and Safety Code, is
294294 amended to read as follows:
295295 Sec. 481.106. CLASSIFICATION OF CONTROLLED SUBSTANCE
296296 ANALOGUE. For the purposes of the prosecution of an offense under
297297 this subchapter involving the manufacture, delivery, or possession
298298 of a controlled substance, Penalty Groups 1, 1-A, [and] 2, and 2-A
299299 include a controlled substance analogue that:
300300 (1) has a chemical structure substantially similar to
301301 the chemical structure of a controlled substance listed in the
302302 applicable penalty group; or
303303 (2) is specifically designed to produce an effect
304304 substantially similar to, or greater than, a controlled substance
305305 listed in the applicable penalty group.
306306 SECTION 4. The change in law made by this Act applies only
307307 to an offense committed on or after the effective date of this Act.
308308 An offense committed before the effective date of this Act is
309309 governed by the law in effect on the date the offense was committed,
310310 and the former law is continued in effect for that purpose. For
311311 purposes of this section, an offense was committed before the
312312 effective date of this Act if any element of the offense occurred
313313 before that date.
314314 SECTION 5. This Act takes effect September 1, 2015.